-
Loading metrics
Open Access
Peer-reviewed
Research Article
Near-Infrared Laser Adjuvant for Influenza Vaccine
-
Satoshi Kashiwagi ,
* E-mail: skashiwagi@partners.org (SK); mpoznansky@partners.org (MCP)
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ -
Jianping Yuan,
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ -
Benjamin Forbes,
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ -
Mathew L. Hibert,
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ -
Eugene L. Q. Lee,
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ -
Laura Whicher,
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ -
Calum Goudie,
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ -
Yuan Yang,
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ -
Tao Chen,
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ -
Beth Edelblute,
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ -
Brian Collette,
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ -
Laurel Edington,
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ -
James Trussler,
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ -
Jean Nezivar,
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ -
Pierre Leblanc,
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ -
Roderick Bronson,
Affiliation Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Kosuke Tsukada,
Affiliation Department of Applied Physics and Physico-Informatics, Faculty of Science and Technology, Keio Universtiy, Kohoku-ku, Yokohama-city, Kanagawa, Japan
⨯ -
Makoto Suematsu,
Affiliation Department of Biochemistry, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan
⨯ -
Jeffrey Dover,
Affiliation SkinCare Physicians of Chestnut Hill, Chestnut Hill, Massachusetss, United States of America
⨯ -
Timothy Brauns,
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ -
Jeffrey Gelfand,
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ - [ ... ],
-
Mark C. Poznansky
* E-mail: skashiwagi@partners.org (SK); mpoznansky@partners.org (MCP)
Affiliation Vaccine and Immunotherapy Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
⨯ - [ view all ]
- [ view less ]
Near-Infrared Laser Adjuvant for Influenza Vaccine
- Satoshi Kashiwagi,
- Jianping Yuan,
- Benjamin Forbes,
- Mathew L. Hibert,
- Eugene L. Q. Lee,
- Laura Whicher,
- Calum Goudie,
- Yuan Yang,
- Tao Chen,
- Beth Edelblute
- Published: December 11, 2013
- https://doi.org/10.1371/journal.pone.0082899